# Cardiology Referral

> **SYNTHETIC RECORD, NOT A REAL MEDICAL RECORD**

- Patient: Susan B. Anthony (real historical name used in a fictional teaching record)
- Synthetic MRN: HR-NI014-SYN-TD
- Date: 1905-03-16
- Fictional facility: St. Posthumous Health Center
- Fictional author: Harold Pemberton, MD
- Calendar frame: true historical dates (modern content is anachronistic)

> True-date frame: synthetic events are moved into the patient's historical lifetime. Codes, instruments, and treatments remain modern and are anachronistic.

- To: Ingrid Solvang, MD, Cardiology
- Urgency: Routine, within two weeks; echocardiogram booked for the same morning

## Referral question

New heart failure in an active 85-year-old woman, likely with preserved ejection fraction. Please confirm the diagnosis, review the echocardiogram, and advise on any specific cause and on therapy. **S**

## Questions for the consultant

1. Does the echocardiogram confirm heart failure with preserved ejection fraction?
2. Is there any sign of a specific cause, such as cardiac amyloidosis, hypertrophic cardiomyopathy, or significant valve disease, that would change treatment?
3. Do you agree with adding spironolactone once potassium and kidney function are stable?
4. Is cardiac rehabilitation or any further testing worthwhile at her level of activity?

## Pertinent history

Three months of breathlessness after one flight of stairs or a long station platform, with ankle swelling by evening and two-pillow orthopnea. NT-proBNP 1650 pg/mL; ECG shows sinus rhythm and left ventricular hypertrophy by voltage, without atrial fibrillation. Blood pressure 158/86 mmHg. Furosemide 20 mg and empagliflozin 10 mg were started today. Never smoker, no diabetes, kidney function near normal (eGFR 64). **S**

- Susan B. Anthony was born on February 15, 1820, in Adams, Massachusetts, the second child of Daniel and Lucy Read Anthony. **D**
- Anthony voted in the 1872 presidential election, was arrested at her Rochester home, and was convicted at Canandaigua, New York; she refused to pay the $100 fine. **D**
- Her father, Daniel Anthony, who had not had a day's illness in forty years, was suddenly stricken in November 1862 with what was called acute neuralgia of the stomach and died two weeks later, on November 25, 1862, at 69. **D**
- Her 1898 biography describes a long-lived family: her mother died at eighty-six, her paternal grandfather lived past ninety-seven, and both maternal grandparents died in their eighty-fourth year. **D**
- In January 1891, after weeks of what seemed a persistent la grippe, Anthony collapsed at the Garrison home in Brookline, Massachusetts; pneumonia threatened and she kept to her room for a week. **D**
- On July 26, 1895, near the end of an address at Lakeside, Ohio, Anthony stopped abruptly and fainted; from July 30 she spent a month in bed with what was called nervous prostration, described as her first serious illness in seventy-five years. **D**
- Her biographer described her daily habits in the late 1890s: a cold sponge bath each morning, simple food, tea and coffee in moderation, a rest after meals and an hour's rest each afternoon, and fresh air and exercise every day, walking from the station after a day on the train. **D**

2 later historical claims are omitted because they describe events after the index age. See the teaching note.

Baseline: NT-proBNP: 1650 pg/mL (high); Sodium: 138 mmol/L; Potassium: 4.1 mmol/L; Creatinine: 0.88 mg/dL; eGFR: 64 mL/min/1.73 m²; Glucose: 96 mg/dL; Magnesium: 2 mg/dL; Hemoglobin: 12.4 g/dL; Ferritin: 140 ng/mL; Transferrin saturation: 24%; TSH: 2.4 mIU/L; HbA1c: 5.5%; LDL cholesterol: 96 mg/dL; ALT: 18 U/L; KCCQ-12 overall summary: 52; PHQ-2: 0. All results are synthetic.

BP 158/86 mmHg; pulse 84 bpm; respirations 20/min; temperature 36.7 °C; oxygen saturation 95% on room air; weight 58.5 kg; BMI 21.5 kg/m². All vital signs are synthetic.

## Current medications

- Furosemide 20 mg oral tablet, one tablet by mouth daily **S**
- Empagliflozin 10 mg oral tablet, one tablet by mouth daily **S**

## Plan so far

- Treat congestion with furosemide and start empagliflozin for HFpEF; move to as-needed furosemide guided by daily weights once euvolemic. Guideline: 2022 AHA/ACC/HFSA Guideline for the Management of Heart Failure (2022); 2023 ACC Expert Consensus Decision Pathway on Management of Heart Failure With Preserved Ejection Fraction (2023) **S**
- Add low-dose spironolactone for HFpEF with blood pressure above target once potassium and kidney function are stable. Guideline: 2022 AHA/ACC/HFSA Guideline for the Management of Heart Failure (2022); 2023 ACC Expert Consensus Decision Pathway on Management of Heart Failure With Preserved Ejection Fraction (2023) **S**
- Check a basic metabolic panel and magnesium one to two weeks after starting or changing diuretic, SGLT2 inhibitor, or mineralocorticoid antagonist therapy, then every three to six months; KCCQ-12 every three to six months. Guideline: 2022 AHA/ACC/HFSA Guideline for the Management of Heart Failure (2022); CMID: Clinical Monitoring Intelligence Database, heart failure monograph (2026) **S**
- Daily weights, sodium moderation, a written travel plan for weight gain, and continued daily walking; refer to cardiac rehabilitation if exercise tolerance plateaus. Guideline: 2022 AHA/ACC/HFSA Guideline for the Management of Heart Failure (2022); CMID: Clinical Monitoring Intelligence Database, heart failure monograph (2026) **S**
- Pneumococcal and RSV vaccination and a yearly high-dose influenza vaccine to lower the risk of respiratory infection in heart failure. Guideline: 2022 AHA/ACC/HFSA Guideline for the Management of Heart Failure (2022); CMID: Clinical Monitoring Intelligence Database, heart failure monograph (2026) **S**
